The AGMA1 polyamidoamine mediates the efficient delivery of siRNA

J Drug Target. 2017 Nov-Dec;25(9-10):891-898. doi: 10.1080/1061186X.2017.1363215. Epub 2017 Aug 18.

Abstract

AGMA1, a prevailingly cationic, guanidine-bearing, linear, amphoteric polyamidoamine is an effective siRNA condensing agent. Here two AGMA1 samples of different molecular weight, i.e. AGMA1-5 and AGMA1-10 were evaluated as siRNA condensing agents and transfection promoters. AGMA1-10 formed stable polyplexes with a size lower than 50 nm and positive zeta potential. AGMA1-5 polyplexes were larger, about 100 nm in size. AGMA1-10 polyplexes, but not AGMA1-5 proved to be an effective intracellular siRNA carrier, able to trigger gene silencing in Hela and PC3 cell lines without eliciting cytotoxic effects. AGMA1-10 knocked down AKT-1 expression upon transfection with an AKT-1 specific siRNA. The polyplex entry mechanism was investigated and was mediated by macropinocytosis. In conclusion, AGMA1 has potential as an efficient, non-toxic tool for the intracellular delivery of siRNA and warrants further investigation.

Keywords: AGMA1; AGMA1/siRNA polyplexes; Polyamidoamine; gene silencing; intracellular siRNA delivery; siRNA.

MeSH terms

  • Agmatine / administration & dosage
  • Agmatine / analogs & derivatives*
  • Agmatine / metabolism
  • Cytoplasm / drug effects
  • Cytoplasm / metabolism
  • Gene Transfer Techniques* / standards
  • HeLa Cells
  • Humans
  • Polyamines / administration & dosage*
  • Polyamines / metabolism
  • RNA, Small Interfering / administration & dosage*
  • RNA, Small Interfering / genetics
  • RNA, Small Interfering / metabolism

Substances

  • AGMA1 polymer
  • Polyamines
  • RNA, Small Interfering
  • Agmatine